NCCN National Comprehensive Cancer Network Directory Information

Similar documents
Managing Older Patients With Lymphoma and Multiple Myeloma

National Cancer Institute Clinical Trial Cooperative Groups

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

RECENT TRENDS. The Impact of the NCI and NIBIB

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

Competent Pain Management for Older Patients With Cancer

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer

APPLICANT INFORMATION

Cooperative Group /JCOG. Multi-modality therapy. Cooperative Group. adjuvant therapy. Chemoradiation % % 7.5% 7.2% 7.0% 2.5% 2.1% 19.

New Surgical Oncology Clinic at Nationwide Children s Hospital

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION

The Clinical Research E-News

The Clinical Research E-News

STANFORD CANCER CENTER. Clinical Studies. A Cancer Center Designated By The National Cancer Institute

The Clinical Research E-News

ILNA Points REFERENCE GUIDE

The Clinical Research E-News

SAMPLE. Survivorship Care Plan for Lymphoma (Diffuse Large B-Cell) General Information. Care team

Care for Children and Adolescents With Cancer: Questions and Answers. Key Points

Overview PAUL J. PETRUSKA, M.D.

Criteria and Application for Men

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

UNC GI Clinics UNC GI Procedures

Quality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study

South West Regional Cancer Program. Cancer Plan

ILNA Points REFERENCE GUIDE

What Can Go Wrong in Radiation Treatment: Data from the RPC. Geoffrey S. Ibbott, Ph.D. and RPC Staff

The European Board of Urology

STANDARDIZED PROCEDURE MANAGEMENT OF CHEMOTHERAPY (ADULT, PEDS)

DEPARTMENT OF MEDICAL ONCOLOGY

Cancer Chemotherapy in Clinical Practice

EASTERN COOPERATIVE ONCOLOGY GROUP

Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah

Guideline for Fertility Preservation for Patients with Cancer

Applicant Information.

Cancer Science nd International Conference on Oncology & Cancer Science. August 06-08, 2018 Berlin, Germany. Hosting Organization

The Clinical Research E-News

Montefiore Einstein Center for Cancer Care. Pioneering Treatments. Extraordinary Possibilities.

2. Please complete a separate application for each physical location. 3. Professional or Read-Only Groups interpreting imaging

Jefferson Kimmel Cancer Center Network Presents: The Clinical Research E-News. January 14, 2009

Faster Cancer Treatment Indicators: Use cases

Radiation Oncology Study Guide

The Clinical Research E-News

Pavilion Pediatrics at Green Spring Station, P.A Falls Road, Suite 260 Lutherville, Maryland Phone (410) Fax (410)

Blood & Marrow Transplant Leukemia Immunotherapy

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

ONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE

The Clinical Research E-News

Breast Cancer Management 2017

Cancer Risk Assessment Questionnaire

Kymriah. Kymriah (tisagenlecleucel) Description

Oncologic Applications of Interleukin-2 (Aldesleukin) When Used as Monotherapy. Original Policy Date

The RPC s Evaluation of Advanced Technologies. AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff

Waiting Times for Suspected and Diagnosed Cancer Patients

Highmark Privileging Application. 1. Complete this application if you provide any diagnostic

2018 Specialty Society Delegate Apportionment

Breast and Cervical Cancer Screening. Annual Breast Cancer Conference. Saturday, April 18, a.m. to Noon.

2010 Sharing Hope Program for men

ILNA CODING GUIDELINES

Clinical Summary Note. Digital photographs. Echo Cardiogram. Mammogram. Angiogram. BMD scan Pet scan. Xray US

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016

Oncology Clinical Program Update. William Sause Medical Director Oncology Clinical Program

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #:

The Clinical Research E-News

Unknown Primary Service for patients at Chesterfield Royal Hospital

We care for you. The University Hospital Muenster, Germany

(FIRST) (MIDDLE) (LAST) STREET: CITY: STATE: ZIP CODE:

Childhood Cancer: A Parent's Guide To Solid Tumor Cancers, 2nd Edition PDF

Rare Cancers: The added value of closer cooperation

Bone Sarcoma (MD Anderson Cancer Care Series)

LARGE TISSUE BANKS, REPOSITORIES, AND CORE FACILITIES

Drug Prior Authorization Form Opdivo (nivolumab)

CAPITAL HEALTH CENTER FOR ONCOLOGY. capitalhealth.org/oncology

Outcomes Report: Accountability Measures and Quality Improvements

The Clinical Research E-News

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #:

Radiation Oncology MOC Study Guide

Cancer Awareness Talk ICPAK 2014

Alliance Organizational Structure. Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation

Cancer Studies at the National Institutes of Health Clinical Center: Questions and Answers. Key Points

HEMATOLOGY AND ONCOLOGY

HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014

NCCN TRENDS DEMOGRAPHICS. Results: November 2013 BASAL CELL CARCINOMA. Distribution of Respondent Types (n = 835) Page 1

Overview...3. Cancer Program.4. Breast Cancer with 5-year Survival Analysis...6. Systemic Therapy.7. Stage of Breast Cancer Diagnosed in

Session II: Academic Research in Breast Cancer: Challenges and Opportunities Robert L. Comis, MD ECOG-ACRIN Group Co-Chair

Trial record 1 of 1 for:

1st Annual Arlington Breast Cancer Symposium

ONCOLOGY MEDICAL HOME ACCREDITATION

The Future of the Peer Review Programme

We are an academic institution What does that mean?

Good News Encino! California s Best health care for kids is right in your backyard.

The OUTBACK Trial. Specific CRF Completion Guidelines

The Clinical Research E-News

DIVISION OF HEMATOLOGY AND ONCOLOGY

THE RIGHT PARTNER CAN MAKE A DIFFERENCE

Our office is located at 2030 Drew Street, Clearwater FL, We are on Drew Street, in between N.E Old Coachman Road and Hercules Avenue.

Capacity Analysis in a Specialized Service: Mapping the Future

CRN SWP Business Intelligence Unit

Making a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:

Transcription:

Please provide the information requested below. The information contained herein is for NCCN purposes only and will not be published without your express written consent below. Name: Last First Middle Initial Credentials: MD, DO, PhD, RN, etc. Titles: Mailing Institution Name Address - line 1 Address - line 2 Address - line 3 E-Mail Address Telephone Number(s): Business Office Patient Appointment Scheduling Cell Phone* Pager* Fax * Cell phone and pager numbers are for internal NCCN use only. These numbers will not be published in any directories without your express written consent. Shipping Address (if different than above) : Institution Name Shipping Address - line 1 Shipping Address - line 2 Shipping Address - line 3 Patient Address (if different than above) : Patient Address - line 1 Patient Address - line 2 Patient Address - line 3 1

I agree that the NCCN may list my name in the NCCN Physician Directory for patient referrals. OR I do not want my name listed in the NCCN Physician Directory for patient referrals. If you agree, which phone number would you like listed? (circle one) Business Appointment Other If you agree, which address would you like listed? (circle one) Mailing Patient Signature Date Please provide the name(s) and contact information for your administrative support staff: Include this individual in all correspondence. 2

***** The following section relates to your clinical interests and practices. Please take a moment to provide the information requested below. Do you treat Adult or Pediatric Oncology Patients? (circle one) Adult Pediatric Both Specialties: MedOnc, RadOnc, GynOnc, etc. Primary Board Specialty? Certified? Specialty Name (Y/N?) (Y/N?) Clinical Cancer Practice(s): (Check all that apply) AIDS Related Malignancies Bone Cancer Brain Cancer Breast Cancer Cancer Genetics/Familial Risk Assessment Childhood Cancers Endocrine/Neuroendocrine Cancers Gastrointestinal Cancers Gynecological Cancers Head & Neck Cancers Leukemia Lung Cancers Lymphoma Multiple Myeloma Quality of Life/Supportive Care Sarcomas Skin Cancer non-melanoma Skin/Melanoma Urologic Cancers Other Areas of Clinical Interest: NCCN Committees/Panels: Group Role ***** If you are interested in participating in the NCCN Oncology Research Program, please continue to the next page. Otherwise, please return your completed forms to: NCCN Directory NCCN 500 Old York Road, Suite 250 Jenkintown, PA 19046 Fax: 215-690-0280 3

***** The following section relates to the NCCN Oncology Research Program and your research interests and practices. If you are interested in becoming an Oncology Research Program Investigator, please take a moment to provide the information requested below. Our records indicate that you have not agreed to become an Oncology Research Program Investigator. Would you like to agree to become an Oncology Research Program Investigator at this time? Yes No If yes, please indicate your areas of interest in the following aspects of Oncology Clinical Trials: Research Cancer Focus: (Check all that apply) AIDS Related Malignancies Bone Cancer Brain Cancer Breast Cancer Cancer Genetics/Familial Risk Assessment Childhood Cancers Endocrine/Neuroendocrine Cancers Gastrointestinal Cancers Gynecological Cancers Head & Neck Cancers Leukemia Lung Cancers Lymphoma Multiple Myeloma Quality of Life/Supportive Care Sarcomas Skin Cancer non-melanoma Skin/Melanoma Urologic Cancers Other Areas of Research Interest: Study Phase(s): (Check all that apply) Phase I Phase II Phase III Phase IV Treatment Modalities: (Check all that apply) Angiogenesis Inhibitor Antithrombotic Therapy Biologic Therapy Bone Marrow Transplant Cell Therapy Chemoprevention Cytokines Developmental Chemotherapy Gene Therapy Hemopoietic Stem Cell Transplantation Hormone Therapy Immunotherapy Molecular Targeted Therapies Pain Palliative Care Peripheral Cell Transplant Radiation Therapy Supportive Care Surgery Tumor Ablation Therapy Vaccines Other (specify) In addition to your interest in serving as an Oncology Research Program Investigator, are you interested in serving as an Expert Consultant to pharmaceutical/biotechnology companies? Yes No 4

Are you active in any of the Cooperative Groups listed below? (Check all that apply) ACOSOG American College of Surgeons Oncology Group AMC AIDS Malignancy Consortium CALGB Cancer & Leukemia Group COG Children's Oncology Group ECOG Eastern Cooperative Oncology Group GOG Gynecologic Oncology Group IRS Intergroup Rhabdomyosarcoma Study NSABP National Surgical Adjuvant Project for Breast and Bowel Cancers NABTT New Approaches to Brain Tumor Therapy NCCTG North Central Cancer Treatment Group PBTC Pediatric Brain Tumor Consortium RTOG Radiation Therapy Oncology Group SWOG Southwestern Oncology Group Other Please provide the name(s) and contact information for the protocol nurse(s)/study coordinator(s) who covers your clinical trials: Study Nurse: Additional Study Staff: I agree to be an investigator for the NCCN Oncology Research Program. I understand that this information will be part of the NCCN Investigator Database and will be used by NCCN to identify investigators for clinical trials. I understand that completion of this questionnaire does not guarantee my selection as an investigator by a pharmaceutical company. I acknowledge that NCCN makes no representations and shall not be held liable for use of this data by NCCN or for the accuracy of data entry by NCCN. Signature Date Please return your completed forms to: NCCN Directory NCCN 500 Old York Road, Suite 250 Jenkintown, PA 19046 Fax: 215-690-0280 5